{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T03:01:51Z","timestamp":1772766111094,"version":"3.50.1"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Membranous glomerulonephritis, also known as membranous nephropathy (MN), is a common cause of nephrotic syndrome in adults. Despite extensive research on MN, bibliometric studies on the subject are scarce. Therefore, this study aimed to provide a visual analysis of global trends in membranous nephropathy research over the past 13\u00a0years.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study conducted a bibliometric and visual analysis of global trends in MN research from 2010 to 2023. Articles related to MN were retrieved from the Web of Science Core Collection (WoSCC) database. Tools such as CiteSpace and VOSviewer were utilized to analyze publications, countries, institutions, authors, publishing journals, co-cited references, and keywords to identify the current state and future trends in MN research.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The analysis encompassed 1,624 publications, showing an annual increase from 2010 to 2023. The People\u2019s Republic of China emerged as the most active country in this field, while France\u2019s Sorbonne Universite and Institut National de la Sante et de la Recherche Medicale (Inserm) led in publication volume among academic institutions. Debiec Hanna stood out as the most prolific author. BMC Nephrology had the highest number of publications, making it the most favored journal in the field. The article with the greatest co-citation intensity was \u201cPrimary Membranous Nephropathy,\u201d a review published in 2017.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study shows that there has been increasing interest in membranous nephropathy over the past 13 years. The most frequently encountered keywords were \u201cmembranous nephropathy\u201d \u201cnephrotic syndrome,\u201d and \u201cglomerulonephritis.\u201d Analysis of emerging terms indicated that \u201ca2 receptor antibody,\u201d \u201cdomain containing 7a,\u201d and \u201ct cell\u201d may remain prominent subjects of research in the forthcoming years. The findings highlight key research trends and areas of interest that can inform researchers, clinicians, and policymakers about the current state of MN research and help guide future research directions and clinical practice.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2024.1426897","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T05:21:29Z","timestamp":1726118489000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Bibliometric and visual analysis of membranous nephropathy literature from 2010 to 2023"],"prefix":"10.3389","volume":"15","author":[{"given":"Yirui","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongnan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pingping","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Congcong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinguo","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1681\/ASN.2016070776","article-title":"A proposal for a serology-based approach to membranous nephropathy","volume":"28","author":"De Vriese","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"983","DOI":"10.2215\/CJN.11761116","article-title":"Primary membranous nephropathy","volume":"12","author":"Couser","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.2215\/CJN.02930322","article-title":"Toxic occupational exposures and membranous nephropathy","volume":"17","author":"Cremoni","year":"2022","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"786334","DOI":"10.3389\/fphar.2021.786334","article-title":"Efficacy and safety of different immunosuppressive therapies in patients with membranous nephropathy and high PLA2R antibody titer","volume":"12","author":"Deng","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B6","article-title":"Little science, big science","author":"de Solla Price","year":"1963"},{"key":"B7","doi-asserted-by":"publisher","first-page":"151316","DOI":"10.1016\/j.semnephrol.2023.151316","article-title":"Epidemiology and outcomes of glomerular diseases in low- and middle-income countries","volume":"42","author":"Ekrikpo","year":"2022","journal-title":"WB Saunders"},{"key":"B8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1056\/NEJMoa1814427","article-title":"Rituximab or cyclosporine in the treatment of membranous nephropathy","volume":"381","author":"Fervenza","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1681\/ASN.2021101323","article-title":"Recurrence of anti-semaphoring 3B\u2013mediated membranous nephropathy after kidney transplantation","volume":"33","author":"Fila","year":"2022","journal-title":"J. Am. Soc. Nephrol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/ndt\/gfx296","article-title":"Genetics of membranous nephropathy","volume":"33","author":"Gupta","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"key":"B11","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00428-019-02558-0","article-title":"Clinicopathological characteristics of thrombospondin type 1 domain-containing 7A-associated membranous nephropathy","volume":"474","author":"Hara","year":"2019","journal-title":"Virchows Arch."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1102036","DOI":"10.3389\/fimmu.2022.1102036","article-title":"Editorial: primary membranous nephropathy","volume":"13","author":"Infantino","year":"2022","journal-title":"Front. Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1038\/s41598-022-07037-2","article-title":"Prevalence of neural epidermal growth factor-like 1-and exostosin 1\/exostosin 2-associated membranous nephropathy: a single-center retrospective study in Japan","volume":"12","author":"Iwakura","year":"2022","journal-title":"Sci. Rep."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e0138841","DOI":"10.1371\/journal.pone.0138841","article-title":"Prevalence of enhanced granular expression of thrombospondin type-1 domain-containing 7A in the glomeruli of Japanese patients with idiopathic membranous nephropathy","volume":"10","author":"Iwakura","year":"2015","journal-title":"Plos One"},{"key":"B15","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10157-019-01712-x","article-title":"Comparison of measurements of anti-PLA2R antibodies in Japanese patients with membranous nephropathy using in-house and commercial ELISA","volume":"23","author":"Kaga","year":"2019","journal-title":"Clin. Exp. Nephrol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/ki.2012.486","article-title":"Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy","volume":"83","author":"Kanigicherla","year":"2013","journal-title":"Kidney Int."},{"key":"B17","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1159\/000440983","article-title":"Anti-phospholipase A2 receptor antibody as prognostic indicator in idiopathic membranous nephropathy","volume":"42","author":"Kim","year":"2015","journal-title":"Am. J. Nephrol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"822508","DOI":"10.3389\/fimmu.2022.822508","article-title":"Strategies towards antigen-specific treatments for membranous nephropathy","volume":"13","author":"K\u00f6llner","year":"2022","journal-title":"Front. Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3233\/hab-1996-7301","article-title":"Membranous nephropathy in primary antiphospholipid syndrome: description of a case and induction of renal injury in SCID mice","volume":"7","author":"Levy","year":"1996","journal-title":"Hum. Antibodies Hybridomas"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.1002\/jcb.27616","article-title":"Improvement of membranous nephropathy by inhibition of miR\u2010193a to affect podocytosis via targeting WT1","volume":"120","author":"Li","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1111\/imj.13233","article-title":"Detection and clinical significance of glomerular M\u2010type phospholipase A2 receptor in patients with idiopathic membranous nephropathy","volume":"46","author":"Liu","year":"2016","journal-title":"Intern. Med. J."},{"key":"B22","first-page":"317","article-title":"The frequency distribution of scientific productivity","volume":"16","author":"Lotka","year":"1926","journal-title":"J. Wash. Acad. Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"297","DOI":"10.17161\/kjm.vol16.20996","article-title":"Lipoic acid as a trigger for NELL-1 positive membranous nephropathy","volume":"16","author":"Nassar","year":"2023","journal-title":"Kans. J. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s40037-021-00695-4","article-title":"Bibliometrics: methods for studying academic publishing","volume":"11","author":"Ninkov","year":"2022","journal-title":"Perspect. Med. Educ."},{"key":"B25","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.ekir.2020.03.023","article-title":"Regulatory B cells are reduced and correlate with disease activity in primary membranous nephropathy","volume":"5","author":"Ramachandran","year":"2020","journal-title":"Kidney Int. Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-021-00303-z","article-title":"Membranous nephropathy","volume":"7","author":"Ronco","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B27","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/MNH.0000000000000697","article-title":"Membranous nephropathy: current understanding of various causes in light of new target antigens","volume":"30","author":"Ronco","year":"2021","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"B28","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.kint.2021.05.015","article-title":"Executive summary of the KDIGO 2021 guideline for the management of glomerular diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int."},{"key":"B29","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1681\/ASN.2020071082","article-title":"New \u2018antigens\u2019 in membranous nephropathy","volume":"32","author":"Sethi","year":"2021","journal-title":"J. Am. Soc. Nephrol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.kint.2019.09.014","article-title":"Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy","volume":"97","author":"Sethi","year":"","journal-title":"Kidney Int."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.kint.2020.05.030","article-title":"Semaphorin 3B\u2013associated membranous nephropathy is a distinct type of disease predominantly present in pediatric patients","volume":"98","author":"Sethi","year":"","journal-title":"Kidney Int."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1681\/ASN.2020081165","article-title":"Protocadherin 7\u2013associated membranous nephropathy","volume":"32","author":"Sethi","year":"2021","journal-title":"J. Am. Soc. Nephrol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1681\/ASN.2018080852","article-title":"Exostosin 1\/exostosin 2\u2013associated membranous nephropathy","volume":"30","author":"Sethi","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1056\/NEJMoa1009742","article-title":"Risk HLA-DQA1 and PLA2R1 alleles in idiopathic membranous nephropathy","volume":"364","author":"Stanescu","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1056\/NEJMoa1409354","article-title":"Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy","volume":"372","author":"Tomas","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/ki.2015.34","article-title":"Serum anti-PLA2R antibodies can be initially absent in idiopathic membranous nephropathy: seroconversion after prolonged follow-up","volume":"87","author":"van de Logt","year":"2015","journal-title":"Kidney Int."},{"key":"B37","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1159\/000431331","article-title":"Renal phospholipase A2 receptor in hepatitis B virus-associated membranous nephropathy","volume":"41","author":"Xie","year":"2015","journal-title":"Am. J. Nephrol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1681\/ASN.2016010093","article-title":"Long-term exposure to air pollution and increased risk of membranous nephropathy in China","volume":"27","author":"Xu","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e21170","DOI":"10.1096\/fj.202001143R","article-title":"sPLA2\u2010IB and PLA2R mediate insufficient autophagy and contribute to podocyte injury in idiopathic membranous nephropathy by activation of the p38MAPK\/mTOR\/ULK1ser757 signaling pathway","volume":"35","author":"Yang","year":"2021","journal-title":"FASEB J."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.12659\/MSM.913057","article-title":"Both peripheral blood and urinary miR-195-5p, miR-192-3p, miR-328-5p and their target genes PPM1A, RAB1A and BRSK1 may be potential biomarkers for membranous nephropathy","volume":"25","author":"Zhou","year":"1903","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1426897\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T05:21:34Z","timestamp":1726118494000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1426897\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,12]]},"references-count":40,"alternative-id":["10.3389\/fphar.2024.1426897"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1426897","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,12]]},"article-number":"1426897"}}